HAYWARD, Calif.--(BUSINESS WIRE)--Feb. 24, 2009--
IMPAX Laboratories, Inc. (OTCBB:IPXL.OB) announced today that its
fourth quarter and full year 2008 earnings will be released before the
market opens on Thursday, February 26, 2009 and will be available on
IMPAX’s Web site at www.impaxlabs.com.
The Company will host an earnings conference call and live webcast with
financial analysts at 11:00 a.m., Eastern time.
The live webcast will be accessible through the Investor Relations
section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers) beginning at least
10 minutes prior to the scheduled start of the call.
A replay of the conference call will be available shortly after the call
until 11:59 p.m. Eastern time on Thursday, March 5, 2009. To access the
replay, dial (800) 642-1687 (in the U.S.) and (706) 645-9291
(international callers). The access conference code is 87487691.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. IMPAX markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the IMPAX Pharmaceuticals division.
Additionally, where strategically appropriate, IMPAX has developed
marketing partnerships to fully leverage its technology platform. IMPAX
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.
Source: IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc.
Mark Donohue, Sr. Director Investor
Relations
215-933-3526
www.impaxlabs.com